Arkolith/Insider Trading/IKNA/Form 4/A

Bonita David P

DirectorIkena Oncology, Inc. (IKNA) · full profile →Form 4/A · filed Sep 21, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 4, 2023Grant(A)153K——5.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 4, 2023Grant(A)353K——353K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000947871-23-000952) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML